Literature DB >> 26567847

Validation of Mitochondrial Gene Delivery in Liver and Skeletal Muscle via Hydrodynamic Injection Using an Artificial Mitochondrial Reporter DNA Vector.

Yukari Yasuzaki1, Yuma Yamada1, Takuya Ishikawa1, Hideyoshi Harashima1.   

Abstract

For successful mitochondrial transgene expression, two independent processes, i.e., developing a mitochondrial gene delivery system and construction of DNA vector to achieve mitochondrial gene expression, are required. To date, very few studies dealing with mitochondrial gene delivery have been reported and, in most cases, transgene expression was not validated, because the construction of a reporter DNA vector for mitochondrial gene expression is the bottleneck. In this study, mitochondrial transgene expression by the in vivo mitochondrial gene delivery of an artificial mitochondrial reporter DNA vector via hydrodynamic injection is demonstrated. In the procedure, a large volume of naked plasmid DNA (pDNA) is rapidly injected. We designed and constructed pHSP-mtLuc (CGG) as a mitochondrial reporter DNA vector that possesses a mitochondrial heavy strand promoter (HSP) and an artificial mitochondrial genome with the reporter NanoLuc (Nluc) luciferase gene that records adjustments to the mitochondrial codon system. We delivered the pDNA into mouse liver mitochondria by hydrodynamic injection, and detected exogenous mRNA in the liver using reverse transcription PCR analysis. The hydrodynamic injection of pHSP-mtLuc (CGG) resulted in the expression of the Nluc luciferase protein in liver and skeletal muscle. Our mitochondrial transgene expression reporter system would contribute to mitochondrial gene therapy and further studies directed at mitochondrial molecular biology.

Entities:  

Keywords:  gene delivery; gene therapy; hydrodynamic injection; mitochondria; transgene expression

Mesh:

Substances:

Year:  2015        PMID: 26567847     DOI: 10.1021/acs.molpharmaceut.5b00511

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy.

Authors:  Rúben Faria; Milan Paul; Swati Biswas; Eric Vivès; Prisca Boisguérin; Ângela Sousa; Diana Costa
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

Review 2.  NanoLuc: A Small Luciferase Is Brightening Up the Field of Bioluminescence.

Authors:  Christopher G England; Emily B Ehlerding; Weibo Cai
Journal:  Bioconjug Chem       Date:  2016-04-19       Impact factor: 4.774

Review 3.  Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective.

Authors:  Alessia Di Donfrancesco; Giulia Massaro; Ivano Di Meo; Valeria Tiranti; Emanuela Bottani; Dario Brunetti
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

4.  NanoLuc Bioluminescence-Driven Photodynamic Activation of Cholecystokinin 1 Receptor with Genetically-Encoded Protein Photosensitizer MiniSOG.

Authors:  Yuan Li; Zong Jie Cui
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

Review 5.  Recent Advances in Mitochondria-Targeted Gene Delivery.

Authors:  Yoon-Ha Jang; Kwang-Il Lim
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

Review 6.  Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.

Authors:  Yuma Yamada; Yusuke Sato; Takashi Nakamura; Hideyoshi Harashima
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

Review 7.  Moving towards clinical trials for mitochondrial diseases.

Authors:  Robert D S Pitceathly; Nandaki Keshavan; Joyeeta Rahman; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2020-09-02       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.